Innovestor Life Science Fund
Helsinkiinnovestorgroup.com
Overview
Innovestor Life Science Fund is a venture capital fund that invests in early-stage biotech and digital health companies in the Nordic and Baltic regions.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Gesynta Pharma AB | Jul 2025 | Series B | Lead |
| Actithera | Jul 2025 | Series A | Co-investor |
| Tribune Therapeutics | Mar 2025 | Series A | Co-investor |
| Neumirna Therapeutics | Jan 2025 | Series A | Co-investor |
| Teitur Trophics | Mar 2023 | Series A | Co-investor |
Key People
Wilhelm Lindholm
CEO, Partner, Partner
Heli Mehtätalo-Takala
Head Of Investor Relations And Communications, Business Advisor, PALO Program
Reima Linnanvirta
Board Member, Member Of Venture Capital Committee, Member Of Tax Committee
Aleksi Huhta
Director, Investor Relations
Hannu Jungman
Partner, Innovestor Ventures
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.